Targets for personalized treatment of conjunctival melanoma
Abstract
This thesis identifies specific targets, illustrates the
role of these targets, and explores personalized therapeutic possibilities to
inhibit tumor growth by using new treatment strategies. And the thesis
describes a new animal model for CM. A proper model can mimic the human disorder and provide opportunities for studying tumor biology, and for seeking novel effective therapies to inhibit the dissemination of malignant cells. Subsequently, the potential role of immune checkpoint molecules and the presence of HLA class I antigens are studied. New animal models and therapeutic targets will broaden our understanding of CM, and help us to develop better treatments for primary and metastatic CM, thus prolonging patients’ survival.
Conjunctival melanomaHLAImmunologyBRAFKinase inhibitorAnimal model

